Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
18/05/2024 | 02:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:SIBN | SI BONE Inc |
07/05/2024 | 22:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:SIBN | SI BONE Inc |
07/05/2024 | 15:00 | GlobeNewswire Inc. | SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures | NASDAQ:SIBN | SI BONE Inc |
06/05/2024 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:SIBN | SI BONE Inc |
06/05/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE, Inc. Reports Financial Results for the First Quarter 2024 | NASDAQ:SIBN | SI BONE Inc |
29/04/2024 | 15:00 | GlobeNewswire Inc. | SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024 | NASDAQ:SIBN | SI BONE Inc |
15/04/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024 | NASDAQ:SIBN | SI BONE Inc |
04/03/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024 | NASDAQ:SIBN | SI BONE Inc |
27/02/2024 | 22:31 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:SIBN | SI BONE Inc |
27/02/2024 | 22:03 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:SIBN | SI BONE Inc |
26/02/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance | NASDAQ:SIBN | SI BONE Inc |
14/02/2024 | 23:07 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:SIBN | SI BONE Inc |
05/02/2024 | 22:09 | GlobeNewswire Inc. | SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024 | NASDAQ:SIBN | SI BONE Inc |
30/01/2024 | 14:30 | GlobeNewswire Inc. | SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application | NASDAQ:SIBN | SI BONE Inc |
08/01/2024 | 14:30 | GlobeNewswire Inc. | SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023 | NASDAQ:SIBN | SI BONE Inc |
02/01/2024 | 22:34 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:SIBN | SI BONE Inc |
14/11/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023 | NASDAQ:SIBN | SI BONE Inc |
06/11/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance | NASDAQ:SIBN | SI BONE Inc |
01/11/2023 | 21:09 | GlobeNewswire Inc. | SI-BONE To Present at Jefferies London Healthcare Conference on November 15, 2023 | NASDAQ:SIBN | SI BONE Inc |
16/10/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE to Report Third Quarter 2023 Financial Results on November 6, 2023 | NASDAQ:SIBN | SI BONE Inc |
05/09/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE, Inc. Announces iFuse Bedrock Granite® Implant System Compatibility with Certain Medtronic CD Horizon® Solera® 5.5/6.0 System Rods | NASDAQ:SIBN | SI BONE Inc |
29/08/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE To Present at Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023 | NASDAQ:SIBN | SI BONE Inc |
07/08/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual Guidance | NASDAQ:SIBN | SI BONE Inc |
19/07/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE to Present at Canaccord Genuity 43rd Annual Growth Conference on August 9, 2023 | NASDAQ:SIBN | SI BONE Inc |
17/07/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE To Report Second Quarter 2023 Financial Results on August 7, 2023 | NASDAQ:SIBN | SI BONE Inc |
21/06/2023 | 00:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SIBN | SI BONE Inc |
16/06/2023 | 22:47 | Edgar (US Regulatory) | Report of Proposed Sale of Securities (144) | NASDAQ:SIBN | SI BONE Inc |
12/06/2023 | 22:05 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SIBN | SI BONE Inc |
24/05/2023 | 22:09 | GlobeNewswire Inc. | SI-BONE To Present at Jefferies 2023 Healthcare Conference on June 7, 2023 | NASDAQ:SIBN | SI BONE Inc |
11/05/2023 | 22:57 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SIBN | SI BONE Inc |